IHE
iShares U.S. Pharmaceuticals ETF [IHE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
IHE Stock Summary
Top IHE Correlated Resources
IHE
Top 10 Correlated ETFs
IHE
Top 10 Correlated Stocks
IHE
In the News
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
A new ETF hit the market Tuesday, creating buzz for its exposure to popular weight-loss drugs, while expanding the roster of thematic ETFs available for investors willing to pay up for stock-picking prowess.
Pharma ETFs in Focus Post Q3 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Eli Lilly Beats on Q3 Earnings: ETFs to Buy
Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/2006.
IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run
iShares U.S. Pharmaceuticals ETF invests almost 80 percent of its assets in its top 10 holdings, and 48.5 percent in just two companies: JNJ and LLY. IHE didn't generate strong or decent yield, but provided price growth over the long run and has been much more effective during bearish market conditions. Stocks in IHE's portfolio possess popular & life-saving drugs and thus are recession resilient as the medication will be needed regardless of any recession.
Pharma ETF (IHE) Hit a 52-Week High
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
6 Best-Performing ETFs of Last Week
Wall Street delivered a mixed performance last week.
3 Sector ETFs That Beat The Market Last Week
Wall Street wrapped up the last week with mixed performances. The pharma and energy sectors were the biggest winners last week.
Pharma ETFs in Focus Post Q2 Earnings
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/2006.
IHE Financial details
IHE Financial Performance
IHE Frequently Asked Questions
What is iShares U.S. Pharmaceuticals ETF stock symbol ?
iShares U.S. Pharmaceuticals ETF is a US stock and trading under the symbol IHE
What is iShares U.S. Pharmaceuticals ETF stock quote today ?
iShares U.S. Pharmaceuticals ETF stock price is $178.3259 today.
Is iShares U.S. Pharmaceuticals ETF stock public?
Yes, iShares U.S. Pharmaceuticals ETF is a publicly traded company.
Company Profile
- Volume Average 30.62K
- Market Capitalization 572.94M
- Headquarters US
- IPO Date 2006-05-05
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
